Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: Inhibitory role mediated by cyclic GMP-dependent protein kinase

Molecular Pharmacology

Volumn 49, Issue 6, 1996, Pages 1058-1070

  Rodriguez Pascual, Fernando ^a   Teresa Miras Portugal, M ^a   Torres, Magdalena ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; GUANYLATE CYCLASE; METHYLENE BLUE; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CATECHOLAMINE RELEASE; CATTLE; CELL MEMBRANE POTENTIAL; CHROMAFFIN CELL; DOSE TIME EFFECT RELATION; DRUG EFFECT; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; ATRIAL NATRIURETIC FACTOR; CALCIUM; CATECHOLAMINES; CATTLE; CHROMAFFIN GRANULES; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; NATRIURETIC PEPTIDE, C-TYPE; NITRIC OXIDE; NITROPRUSSIDE; PROTEINS;

EID: 0038933880     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Stryer, L. Cyclic GMP cascade of vision. Annu. Rev. Neurosci. 9:87-119 (1986).
2. Lincoln, T. M., P. Komalavilas, and T. L. Cornwell. Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension 23:1141-1147 (1994).
3. Schuman, E. M., and D. V. Madison. Nitric oxide and synaptic function. Annu. Rev. Neurosci. 17:153-183 (1994).
4. Burgoyne, R. D. Control of exocytosis in adrenal chromaffin cells. Biochim. Biophys. Acta 1071:174-202 (1991).
5. Ignarro, L. J., G. M. Buga, K. S. Wood, E. E. Byrns, and G. Chadhuri. Endothelium-derived relaxing factor produced and released from artery and veins is nitric oxide. Proc. Natl. Acad Sci. USA 84:9265-9269 (1987).
6. Palacios, M., R. G. Knowles, E. M. J. Palmer, and S. Moncada. Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochem. Biophys. Res. Commun. 165:802-809 (1989).
7. Torres, M., G. Ceballos, and R. Rubio. Possible role of nitric oxide in catecholamine secretion by chromaffin cells in the presence and absence of cultured endothelial cells. J. Neurochem. 63:988-996 (1994).
8. Dun, N. J., S. L. Dun, S. Y. Wu, and U. Förstermann. Nitric oxide synthase immunoreactivity in rat superior cervical ganglia and adrenal glands. Neurosci. Lett. 158:51-54 (1993).
9. Moro, M. A., P. Michelena, P. Sanchez-Garcia, R. Palmer, S. Moncada, and A. G. Garcia. Activation of adrenal medullary L-arginine:nitric oxide pathway by stimuli which induce release of catecholamines. Eur. J. Pharmacol. 246:213-218 (1993).
10. Oset-Gasque, M. J., M. Parramón, S. Hortelano, L. Boscá, and M. P. González. Nitric oxide implication in the control of neurosecretion by chromaffin cells. J. Neurochem. 63:1693-1700 (1994).
11. 2+ in the down-regulation of cGMP signaling. Biochem. Pharmacol. 50:763-769 (1995).
12. Aunis, D., M. Pescheloche, and J. Zwiller. Guanylate cyclase from bovine adrenal medulla: subcellular distribution and studies on the effect of lysolecithin on enzyme activity. Neuroscience 3:83-93 (1978).
13. 2 receptor. J. Neurochem. 64: 1080-1087 (1995).
14. Babinski, K., J. Féthière, M. Roy, A. De Léan, and H. Ong. C-type natriuretic peptide in bovine chromaffin cells. FEBS Lett. 313:300-302 (1992).
15. Suga, S. I., H. Itoh, Y. Komatsu, Y. Ogawa, N. Kama, T. Yoshimasa, and K. Nakao. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells, evidence for CNP as a novel autocrine/ paracrine regulator from endothelial cells. Endocrinology 133:3038-3041 (1993).
16. 2+ influx in bovine chromaffin cells. Neuroscience 67:149-157 (1995).
17. Tsutsui, M., N. Yanagihara, K. Minami, H. Kobayashi, Y. Nakashima, A. Kuroiwa, and F. Izumi. C-type natriuretic peptide stimulates catecholamine synthesis through the accumulation of cyclic GMP in cultured bovine adrenal medullary cells. J. Pharmacol. Exp. Ther. 268:584-589 (1994).
18. Derome, G., R. Tseng, P. Mercier, I. Lemaire, and S. Lemaire. Possible muscarinic regulation of catecholamine secretion mediated by cyclic GMP in isolated bovine adrenal chromaffin cells. Biochem. Pharmacol. 30:855-860 (1981).
19. O'Sullivan, A. J., and R. D. Burgoyne. Cyclic GMP regulates nicotinic-induced secretion from cultured bovine adrenal chromaffin cells: effects of 8-bromo-cyclic GMP, atrial natriuretic peptide and nitroprusside (nitric oxide). J. Neurochem. 54:1805-1808 (1990).
20. 2+-influx by 8-bromo-guanosine-3′:5′-monophosphate, cyclic (8-Br-cGMP) in bovine adrenal chromaffin cells. Neurosci. Lett. 180:269-272 (1994)
21. Miura, Y., V. Campese, V. DeQuattro, and D. Meijer. Plasma catecholamines via an improved fluorimetric assay: comparison with an enzymatic method. J. Lab. Clin. Med. 89:421-127 (1977).
22. Grynkiewicz, G., M. Poenie, and R. Y. Tsien. A new generation of calcium indicators with greatly improved fluorescence properties. J. Biol Chem. 240:3440-3450 (1985).
23. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J. Biol. Chem 264:1146-1155 (1989).
24. Schmidt, H H. H. W, S. M. Lohmann, and U. Walter. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochem. Biophys. Acta 1178:153-175 (1993).
25. Wilson, S. Pertussis toxin enhances proenkephalin synthesis in bovine chromaffin cells. J Neurochem. 61:1901-1906 (1993).
26. Butt, E., M. Eigenthaler, and H G. Geniesser. (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor. Eur. J. Pharmacol. 269: 265-268 (1994).
27. 2+ current modulated by cGMP-dependent protein kinase. Nature (Lond.) 369:336-339 (1994).
28. Brune, B., and E. G. Lapetina. Activation of a cytosolic ADP-ribosyltransferase by nitric oxide generating agents. J. Biol. Chem. 264:8455-8458 (1989).
29. Trachte, G. J. Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens. J. Pharmacol. Exp. Ther. 264:1227-1233 (1993).
30. Merkel, L. Zaprinast: a cGMP-selective phosphodiesterase inhibitor. Cardiovasc Drug Rev. 11:501-515 (1993).
31. 2+ channels dominate the control of secretion in bovine chromaffin cells. FEBS Lett. 349:331-337 (1994).
32. Desolé, M. S., W. K. Kim, R. A. Rabin, and S. G. Laychock. Nitric oxide reduces depolarization-induced calcium influx in PC12 cells by a cyclic GMP-mediated mechanism. Neuropharmacology 33:193-198 (1994).
33. Boulton, C. L., A. J. Irving, E. Southam, B. Potier, J. Garthwaite, and G. L. Collingridge. The nitric oxide-cyclic GMP pathway and synaptic depression in rat hippocampal slices. Eur. J. Neurosci. 6:1528-1535 (1994).
34. Lindgren, C. A., and M. V. Laird. Nitroprusside inhibits neurotransmitter release at the frog neuromuscular junction. Neuroreport 5:2205-2208 (1994).
35. 2+ currents through a mechanism independent of cGMP-dependent protein kinase. Neuron 1:693-699 (1988).
36. 2+ influx. J. Biol. Chem. 268:12645-12653 (1994).
37. Koller, K. J., and D. V. Goeddel. Molecular biology of the natriuretic peptides and their receptors. Circulation 86:1081-1088 (1992).
38. Butt, E., J. Geiger, T. Jarchau, S. M. Lohmann, and U. Walter. The cGMP-dependent protein kinase: gene, protein and function. Neurochem. Res. 18:27-42 (1993).
39. Brown, A. M., and L. Birmbaumer. Ionic channels and their regulation by G protein subunits. Annu. Rev. Physiol. 58:197-213 (1990).
40. 2+-dependent catecholamine release and the ADP-ribosylation of a 40 KDa protein in bovine adrenal chromaffin cells. FEBS Lett. 234:439-445 (1988).